Profil
Heather Adkins Huet is currently the Director at Gammadelta Therapeutics Ltd. and the Chief Scientific Officer at Day One Biopharmaceuticals, Inc. Dr. Huet holds a doctorate from Harvard University and completed undergraduate studies at The University of Texas at Austin.
Postes actifs de Heather Huet
| Sociétés | Poste | Début |
|---|---|---|
| DAY ONE BIOPHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | - |
Gammadelta Therapeutics Ltd.
Gammadelta Therapeutics Ltd. BiotechnologyHealth Technology Operates biotechnology company that engages in discovery and development of allogeneic gamma delta T cell therapies for cancer | Directeur/Membre du Conseil | - |
Formation de Heather Huet
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Austin
The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gammadelta Therapeutics Ltd.
Gammadelta Therapeutics Ltd. BiotechnologyHealth Technology Operates biotechnology company that engages in discovery and development of allogeneic gamma delta T cell therapies for cancer | Health Technology |
Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes targeted therapies for cancers | Health Technology |
















